We are live on ! Find out more

14 hedge funds and large institutions have $442K invested in Imunon in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.03% more ownership

Funds ownership: 0.27%0.3% (+0.03%)

7% less funds holding

Funds holding: 1514 (-1)

18% less capital invested

Capital invested by funds: $539K → $442K (-$97.4K)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

IMNN Hedge Fund Activity: Q2 2024 in Review

14 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q2 2024, worth a combined $442K — down 18% from $539K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of IMNN and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 5 added.

The largest buyer was UBS Group, adding an estimated $17.5K. The largest seller was Fidelity Investments, exiting entirely with an estimated $238 sold.

  • 14 institutional investors held Imunon (IMNN) as of Q2 2024, down from 15 in Q1 2024.
  • Funds reported $442K of Imunon stock for Q2 2024, down 18% quarter-over-quarter.
  • 2 funds opened new Imunon positions in Q2 2024 and 3 closed out, a net change of -1 holder.
  • The largest Imunon buyer in Q2 2024 was UBS Group, an estimated $17.5K added.
  • The largest Imunon seller in Q2 2024 was Fidelity Investments, an estimated $238 sold.

Based on aggregated 13F filings for Q2 2024.